183 filings
Page 3 of 10
6-K
EVAX
Evaxion Biotech A/S
13 Oct 23
Current report (foreign)
4:45pm
6-K
EVAX
Evaxion Biotech A/S
5 Oct 23
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
8:30am
6-K
EVAX
Evaxion Biotech A/S
27 Sep 23
Current report (foreign)
4:45pm
6-K
EVAX
Evaxion Biotech A/S
25 Sep 23
Current report (foreign)
4:45pm
424B4
EVAX
Evaxion Biotech A/S
13 Sep 23
Prospectus supplement with pricing info
4:45pm
6-K
EVAX
Evaxion Biotech A/S
11 Sep 23
Current report (foreign)
8:17am
6-K/A
EVAX
Evaxion Biotech A/S
7 Sep 23
Current report (foreign) (amended)
4:45pm
EFFECT
EVAX
Evaxion Biotech A/S
31 Aug 23
Notice of effectiveness
12:15am
6-K
EVAX
Evaxion Biotech A/S
29 Aug 23
Evaxion announces Executive Management Changes to strengthen the AI-strategy
9:22am
POS AM
EVAX
Evaxion Biotech A/S
25 Aug 23
Prospectus update (post-effective amendment)
5:00pm
6-K/A
EVAX
Evaxion Biotech A/S
18 Aug 23
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
9:28am
6-K
EVAX
Evaxion Biotech A/S
17 Aug 23
Current report (foreign)
4:58pm
6-K
EVAX
Evaxion Biotech A/S
17 Aug 23
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
4:45pm
6-K
EVAX
Evaxion Biotech A/S
11 Aug 23
Current report (foreign)
4:45pm
6-K
EVAX
Evaxion Biotech A/S
4 Aug 23
Current report (foreign)
4:45pm
6-K
EVAX
Evaxion Biotech A/S
1 Aug 23
Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
7:00am
6-K
EVAX
Evaxion Biotech A/S
31 Jul 23
Current report (foreign)
4:45pm
6-K
EVAX
Evaxion Biotech A/S
31 Jul 23
Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
7:00am
6-K
EVAX
Evaxion Biotech A/S
11 Jul 23
Current report (foreign)
9:14am
6-K
EVAX
Evaxion Biotech A/S
5 Jun 23
Current report (foreign)
8:32am